ROGERIO F. CORREA de OLIVEIRA, M.D.; LEONIDAS P. NOVAES, M.D.; MAURICIO B. LIMA, M.D.; JAYME RODRIGUES, M.D.; SERGIO FRANCO, M.D.; AFAF I. KHENAIFES, M.D.; CLEA P. FRANCALANCI, Pharm.C.
Twenty-four hirsute female patients were treated with 100 mg of depo-medroxyprogesterone acetate intramuscularly every 15 days. Twenty-three showed definite improvement from their abnormal hair growth. All patients with initially elevated 17-ketosteroids in 24-hour urine collections showed a decrease of these metabolites with treatment. In eleven patients the initial plasma testosterone level was elevated and returned to normal values with treatment. The first patient who was submitted to this therapy stopped the treatment for 5 months and started having abnormal hair growth again. With other patients, after initial treatment with depo-medroxyprogesterone acetate intramuscularly, we started using contraception pills containing medroxyprogesterone; this maintained the reduced ectopic hair growth. The most important side effect was amenorrhea.
CORREA de OLIVEIRA RF, NOVAES LP, LIMA MB, RODRIGUES J, FRANCO S, KHENAIFES AI, et al. A New Treatment for Hirsutism. Ann Intern Med. ;83:817–819. doi: 10.7326/0003-4819-83-6-817
Download citation file:
Published: Ann Intern Med. 1975;83(6):817-819.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Hospital Medicine.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use